CLAIM #12140 · Bristol-Myers Squibb Company (BMY) · 2025Q1 earnings call · Apr 24, 2025 · due Dec 31, 2027
“We've already communicated. We still look forward to the readout for the ACN SSP trial in 2026, and then AF is in 2027.”
Samit Hirawat · Chief Medical Officer
PENDING
graded after results covering Dec 31, 2027 are reported
How to check this claim
Look at: Disclosure of topline/readout results for the ACS SSP (acute coronary syndrome) trial and the AF (atrial fibrillation) trial
It came true if: Company or trial sponsor publicly reports readout/topline data for the SSP trial during 2026, and for the AF trial during 2027
Where: Company press releases, earnings call commentary, and clinicaltrials.gov posting of trial results
Verify independently
SEC filings for BMY ↗ · Claim quote is verbatim from the 2025Q1 earnings call.